Biological aspects of neuroblastoma screening
β Scribed by Brodeur, Garrett M.; Ambros, Peter F.; Favrot, Marie C.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 62 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Abbreviations: CR β«Χ‘β¬ complete response; VGPR β«Χ‘β¬ very good partial response; HSR β«Χ‘β¬ homogeneously
π SIMILAR VOLUMES
General consideration is given to available data on screening and ethics. The particular ethical and psychological aspects of screening for neuroblastoma in very young children are highlighted. Major aspects include differences between screening and curative medecine, responsabilities in screening,
## Background: Although multifocal neuroblastoma is rare, its incidence has increased because of recent improvements in diagnostic tools and the introduction of mass screening. among the 106 neuroblastoma cases treated at the authors' hospital between 1984 and 1998, 8 were multifocal neuroblastoma.
A pilot study of neuroblastoma mass screen-screening (one stage I, three stage II, one stage ing was initiated in January 1990 in the Rho Λne III, three stage IVs). All are alive and well but French district. The expected number of births were good prognosis cases according to the per year is 26,000
## BACKGROUND. The Quebec Neuroblastoma Screening (QNS) Project completed a 5-year program for measuring urinary vanillylmandelic acid (VMA)/homovanillic acid (HVA) levels at age 3 weeks and/or 6 months in 89% of 476,603 Quebec-born infants from 1989 -1994; 45 screening positive preclinical cases